Staphylococcus aureus Cowan I-induced human immunoglobulin responses: preferential IgM rheumatoid factor production and VH3 mRNA expression by protein A-binding B cells
- PMID: 7559917
- DOI: 10.1007/BF01543106
Staphylococcus aureus Cowan I-induced human immunoglobulin responses: preferential IgM rheumatoid factor production and VH3 mRNA expression by protein A-binding B cells
Abstract
Protein A (PA), a cell wall component of SAC, activates human B cells by cross-linking the Fabs of membrane immunoglobulins. Recent data indicate that PA binds only to Fabs that use VH3 heavy chains, and thus it has been designated as a B-cell superantigen. We previously reported that Staphylococcus aureus Cowan I (SAC)-induced IgM rheumatoid factor (RF) by human PBMC was mediated by PA. Therefore, we sought to determine if SAC-induced IgMRF production was confined to PA-binding B cells and if these B cells were enriched for the expression of VH3 heavy chains. We observed that the elicitation of IgMRF in response to SAC was limited to a subset of B cells that bind PA and that this subset was enriched for VH3 mRNA expression. Taken together, these results suggest that IgMRFs produced in response to SAC are enriched for usage of VH3 heavy chains. Thus, this SAC-induced autoantibody response appears to represent a new B-cell superantigenic property of PA.
Similar articles
-
Differential binding avidities of human IgM for staphylococcal protein A derive from specific germ-line VH3 gene usage.J Immunol. 1996 Oct 1;157(7):2976-81. J Immunol. 1996. PMID: 8816405
-
Selective activation of VH3A10+ rheumatoid factor producing B cells by staphylococcal enterotoxin D.Int Immunol. 1995 Mar;7(3):425-34. doi: 10.1093/intimm/7.3.425. Int Immunol. 1995. PMID: 7794822
-
Molecular basis for the interaction between human IgM and staphylococcal protein A.Clin Immunol Immunopathol. 1994 Sep;72(3):394-401. doi: 10.1006/clin.1994.1158. Clin Immunol Immunopathol. 1994. PMID: 8062451
-
Staphylococcal protein A binding to VH3 encoded immunoglobulins.Int Rev Immunol. 1997;14(4):291-308. doi: 10.3109/08830189709116521. Int Rev Immunol. 1997. PMID: 9186782 Review.
-
A B-cell superantigen that targets B-1 lymphocytes.Curr Top Microbiol Immunol. 2000;252:251-63. doi: 10.1007/978-3-642-57284-5_26. Curr Top Microbiol Immunol. 2000. PMID: 11125483 Review. No abstract available.
Cited by
-
scFv-based "Grababody" as a general strategy to improve recruitment of immune effector cells to antibody-targeted tumors.Cancer Res. 2013 Apr 15;73(8):2619-27. doi: 10.1158/0008-5472.CAN-12-3920. Epub 2013 Feb 8. Cancer Res. 2013. PMID: 23396586 Free PMC article.
-
Staphylococcus aureus isolates from patients with Kawasaki disease express high levels of protein A.Infect Immun. 1999 Sep;67(9):4737-43. doi: 10.1128/IAI.67.9.4737-4743.1999. Infect Immun. 1999. PMID: 10456925 Free PMC article.
-
B-cell superantigens: definition and potential impact on the immune response.J Clin Immunol. 1995 Nov;15(6 Suppl):26S-36S. doi: 10.1007/BF01540891. J Clin Immunol. 1995. PMID: 8613489
-
Death by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a Staphylococcal Toxin.J Exp Med. 2003 May 5;197(9):1125-39. doi: 10.1084/jem.20020552. Epub 2003 Apr 28. J Exp Med. 2003. PMID: 12719481 Free PMC article.
-
Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps.J Allergy Clin Immunol. 2017 Apr;139(4):1195-1204.e11. doi: 10.1016/j.jaci.2016.06.066. Epub 2016 Sep 19. J Allergy Clin Immunol. 2017. PMID: 27658758 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources